RP Optical Lab Ltd.
TTASE:RPOL3,994.00
ILA
+32.00
(+0.81%)
ISIN
IL0012224627
Return %
Stock
S&P 500
1Y
139.59
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
USD
•
in mil. unless spec.Working Capital
USD
•
in mil. unless spec.Growth Rates
USD
•
in mil. unless spec.Quarterly Revenue
USD
•
in mil. unless spec.Quarterly Earnings Per Share
USD
•
in mil. unless spec.Quarterly Dividends Per Share
USD
•
in mil. unless spec.Company Description
- CEO
- Dror Sharon
- Full Time Employees
- 82
- Sector
- Electronic technology
- Industry
- Electronic components
- Address
- 3 Shimshon St Building B Petach Tikva Israel 4952701
- IPO Date
- Jun 4, 2025
- Website
- rp-optical-lab.com
- Similar Companies
- Business
- RP Optical Lab Ltd operates as a specialized ophthalmic optics manufacturer and provider of advanced optical solutions. The company designs, fabricates, and distributes high-precision spectacle lenses, specialty optics, and related ophthalmic products for vision care providers and (where applicable) end users. Its product suite encompasses refractive and diagnostic lenses, precision-ground optics, adaptive and photochromic coating technologies, and custom lens products tailored to specific clinical needs. Main products and services: spectacle lenses (single-vision, progressive, digital free-form; high-index and lightweight materials; specialty coatings and tints), ophthalmic optics components (lens blanks, coatings, edgers, adapters), diagnostic and measurement tooling (phoropter-related accessories, lensometers, software for prescription validation), custom optical solutions (engineered free-form designs, aspheric and toric lens configurations), production services (lens shaping, edging, coating application, quality assurance testing), and related support services (prescription verification, technical training, service and warranty offerings). Latest major company changes: RP Optical Lab Ltd enters strategic partnerships with regional ophthalmology distributors to expand market reach; completes targeted acquisitions within the ophthalmic lens manufacturing ecosystem to broaden technology capabilities and product breadth; launches new adaptive and photochromic coating options and a digital lens customization platform; expands manufacturing footprint and distribution across additional geographies; undergoes organizational restructuring to enhance product development, customer service, and regulatory compliance. Additional context: The company operates within the ophthalmic optics industry, serving optometrists, ophthalmologists, eyewear retailers, and vision care chains. Geographic operations span multiple regions, with manufacturing and distribution hubs likely in the company’s core market and selected international markets. Founding year and headquarters location are identified in corporate materials, with potential subsidiaries or parent company relationships. The business emphasizes high-precision lens fabrication, coatings technology, and tailored optical solutions to meet clinical prescriptions and patient needs.